Cancer

Stanford Medicine researchers found the treatment can cause mild cognitive impairment – and identified compounds that may help reverse it.

Stanford Medicine scientists have created a liquid biopsy test capable of detecting cancers, molecular mechanisms of resistance to treatment, and tissue injury.

Using a type of catalog called a “colocatome,” Stanford Medicine researchers are capturing how healthy cells surrounding tumors influence cancer cell behavior – and how those interactions can inform treatments.

Stanford Medicine’s Minimally Invasive MR Interventional Center uses two types of therapy to treat prostate cancer without surgery, radiation, or chemotherapy. The first patient to undergo the procedures is now free of the disease.

A new Stanford Medicine study has identified single nucleotide variants that are essential to drive cancer growth. The findings could enhance genetic screening and aid in the development of new therapies.

TRACeR platforms more accurately recognize a wide variety of surface proteins expressed by cancer cells that make them easier to target with the body’s own immune system.

CAR-T cells show promise against tumors that are among the deadliest cancers, a Stanford Medicine trial found.

New studies are helping scientists better understand small circles called ecDNA. Dismissed as inconsequential until recently, they are major drivers of many types of human cancers.

By switching on a natural process that triggers cell death, researchers hope to trick cancer cells into disposing of themselves.

Targeted cell therapy helps some patients with intractable lymphoma, but those who relapse have few options. Stanford Medicine researchers found that modifying the molecular target significantly improved outcomes.